European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives (Q38062360)

28 August 2017

1 reference

title

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives (English)

1 reference

28 August 2017

11

1 reference

28 August 2017

Emir Hadzijusufovic

9

0 references

Frank Siebenhaar

Frank Siebenhaar

22

0 references

Gunnar Nilsson

Gunnar Nilsson

17

0 references

Massimo Triggiani

Massimo Triggiani

25

0 references

Hanneke C Kluin-Nelemans

Hanneke C Kluin-Nelemans

13

0 references

Marek Niedoszytko

15

Marek Niedoszytko

1 reference

28 August 2017

14

Marcus Maurer

1 reference

28 August 2017

19

Alberto Orfao

1 reference

28 August 2017

16

Boguslaw Nedoszytko

1 reference

28 August 2017

24

Wolfgang R Sperr

1 reference

28 August 2017

Peter Valent

1

1 reference

28 August 2017

Michel Arock

2

1 reference

28 August 2017

Patrizia Bonadonna

3

1 reference

28 August 2017

Knut Brockow

4

1 reference

28 August 2017

Sigurd Broesby-Olsen

5

1 reference

28 August 2017

Luis Escribano

6

1 reference

28 August 2017

Karoline V Gleixner

7

1 reference

28 August 2017

Clive Grattan

8

1 reference

28 August 2017

Hans Hägglund

10

1 reference

28 August 2017

Hans-Peter Horny

12

1 reference

28 August 2017

Hanneke N G Oude-Elberink

18

1 reference

28 August 2017

Deepti Radia

20

1 reference

28 August 2017

Andreas Reiter

21

1 reference

28 August 2017

Karl Sotlar

23

1 reference

28 August 2017

Jaap J VanDoormaal

26

1 reference

28 August 2017

Judit Várkonyi

27

1 reference

28 August 2017

Selim Yavuz

28

1 reference

28 August 2017

Karin Hartmann

29

1 reference

28 August 2017

publication date

20 November 2012

1 reference

28 August 2017

published in

Vienna Clinical Weekly

1 reference

28 August 2017

volume

124

1 reference

28 August 2017

issue

23-24

1 reference

28 August 2017

page(s)

807-814

1 reference

Mast cells and mast cell neoplasia: a review

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Classification and diagnosis of mastocytosis: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Erythema following imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Mastocytosis: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Mast cells and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Mast cell proliferative disorders: current view on variants recognized by the World Health Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Diagnosis, progression patterns and prognostication in mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Mastocytosis: mediator-related signs and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Mastocytosis: current concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Mast cell activation syndrome: Proposed diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Cutaneous mastocytosis -- clinical heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Gastrointestinal involvement and manifestations in systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

The European Competence Network on Mastocytosis (ECNM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00508-012-0293-Z

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

21 January 2018

1 reference

12 December 2020

Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications

1 reference

12 December 2020

Systemic mastocytosis

1 reference

12 December 2020

Urticaria pigmentosa; a report of a case with autopsy

1 reference

12 December 2020

Mastocytosis presenting as a skeletal disorder

1 reference

12 December 2020

Diagnostic value of immunostaining for tryptase in patients with mastocytosis

1 reference

12 December 2020

Diagnosis and treatment of systemic mastocytosis: state of the art.

1 reference

12 December 2020

Tissue mast cell leukemia

1 reference

12 December 2020

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults

1 reference

12 December 2020

Mast cell leukemia? Malignant mastocytosis with leukemia-like manifestations

1 reference

12 December 2020

Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis

1 reference

12 December 2020

Biology, classification and treatment of human mastocytosis.

1 reference

12 December 2020

10.1007/S00508-012-0293-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1011088861

0 references

1 reference